X-ray-Induced Cherenkov Optical Triggering of Caged Doxorubicin Released to the Nucleus for Chemoradiation Activation.
Cuiping YaoJiong LiXu CaoJason R GunnMing WuShudong JiangBrian W PoguePublished in: ACS applied materials & interfaces (2020)
Concurrent chemoradiotherapy is used for advanced cancers, but the chemotherapy is dose limited by normal tissue toxicity. Localized X-ray activation of chemotherapy could overcome this, as studied here, with release from self-assembled nanomicelles (NMs) created from copolymers loaded with doxorubicin (DOX) having a photocleavable o-nitrobenzyl ester (o-Ne) group. The micelles demonstrated release of DOX from X-ray-induced Cherenkov light and conversion from a caged hydrophobic form to hydrophilic DOX, which achieves nuclear localization. Folate on the exterior of the NMs directed them for effective intracellular uptake prior to irradiation. Irradiation with 8 Gy released the DOX, which then entered the cell nucleus, providing near-complete in vivo tumor eradication and negligible off-target organ damage. Micelles were assembled from molecular component materials that are commonly in human use. This study realizes triple targeting in chemoradiation with potential for cell-receptor-mediated uptake, localized radiotherapy activation, and nuclear relocalization, all leading to limited off-target toxicity.
Keyphrases
- locally advanced
- drug delivery
- cancer therapy
- rectal cancer
- high resolution
- squamous cell carcinoma
- radiation therapy
- oxidative stress
- high glucose
- diabetic rats
- single cell
- endothelial cells
- dual energy
- cell therapy
- radiation induced
- drug release
- risk assessment
- magnetic resonance imaging
- young adults
- magnetic resonance
- mesenchymal stem cells
- tandem mass spectrometry
- bone marrow
- wound healing
- pluripotent stem cells
- hyaluronic acid
- single molecule